The formulation demonstrated effective mucoadhesion ... This innovative approach combines advanced materials with traditional buccal film technology to enhance drug delivery efficiency [5].
Libervant Buccal Film, a formulation of the drug diazepam, was approved for the treatment of children aged two to five years in April 2024. The product was originally granted Orphan Drug ...
“Our ODF formulations can help to improve patient ... film or extended-release delivery in the form of a buccal or gum film. Drugs with a single API, as well as drug combinations, can be ...
VLS-01, an oral formulation of N,N-dimethyltryptamine (DMT), is designed to be administered via a buccal film applied to the lining of the cheek. This delivery method aims to induce a short ...
Aquestive Therapeutics (AQST) announced the U.S. Food and Drug Administration, FDA, has granted seven years of orphan drug exclusivity, ODE, to Libervant Buccal Film for the acute treatment of ...